Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
38731 POSTS 0 COMMENTS

AAN: Obstructive Sleep Apnea Linked to Increased Incidence of Parkinson Disease

0

Incidence of Parkinson disease significantly lower with early CPAP treatment, but no reduction seen with late CPAP treatment

2008 to 2022 Saw Declines in Cervical Precancers in Women Aged 20 to 24...

0

Among women aged 20 to 24 years who were screened for cervical cancer, rates decreased by 79, 80 percent for CIN2+, CIN3+

Duke Doctors Perform First Living Mitral Valve Transplant

0
By I. Edwards HealthDay Reporter MONDAY, March, 3, 2025 (HealthDay News) -- In a groundbreaking series of surgeries, doctors at Duke Health have successfully performed...

RFK Jr. Says New HHS Decisions No Longer Required to Be Open for Public...

0

Newly appointed health secretary believes processing the comments under the Richardson Waiver puts too heavy a burden on the department

CDC IDs Trends in Pediatric Flu Deaths With Influenza-Linked Encephalopathy

0

Based on preliminary data for 2024 to 2025, 13 percent of pediatric deaths had influenza-associated encephalopathy, encephalitis

Longtime NIH Leader Francis Collins Retires

0
By I. Edwards HealthDay Reporter MONDAY, March 3, 2025 (HealthDay News) -- Dr. Francis Collins, the famed geneticist who led the National Institutes of Health...

GLP-1 Receptor Agonist Use Not Linked to Increased Suicide Risk

0

After adjustment for confounding variables, no increased risk seen for GLP-1 receptor agonists versus DPP-4 inhibitors, SGLT-2 inhibitors

Mortality Increased With Hospital-Based Care for Hallucinogen Use

0

People with acute care involving hallucinogens have greater risk for death by unintentional drug poisoning, suicide

AAAAI: Omalizumab Superior to Oral Immunotherapy in Multifood Allergy

0

Most patients include dietary consumption of allergy-triggering foods after gaining tolerance

Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk Factors

0

Sotagliflozin can also significantly reduce the rate of myocardial infarction and stroke compared with placebo